We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics. To learn more, please read our privacy policy.
Pfizer announced today that the Hong Kong Department of Health (DoH) has approved the company's 20-valent Pneumococcal Conjugate Vaccine (PCV20) for active immunization for the prevention of invasive ...